Tinea Capitis: Trends in Spain

The document from 2012 discusses the situation of tinea capitis in Spain, indicating that while the incidence of this scalp fungal infection decreased with the introduction of griseofulvin treatment, the current prevalence is unknown and the infection remains a public health concern. It highlights a shift in the causative agents from zoophilic to a greater diversity of species, including an increase in anthropophilic dermatophytes, partly due to immigration. The document stresses the need for proper diagnosis, treatment, and prevention to prevent an epidemic, with griseofulvin being the preferred treatment for children and terbinafine as an alternative. It also points out the issue of incorrect or inadequate treatment and the lack of proper treatment guidelines, emphasizing the importance of surveillance, especially in schools, and collaboration among healthcare professionals to manage tinea capitis effectively.